Compounds and methods for detection of enzymes that remove formyl, succinyl, methyl succinyl or myristoyl groups from epsilon-amino lysine moieties

US9963734B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9963734-B2
Application numberUS-201715464966-A
CountryUS
Kind codeB2
Filing dateMar 21, 2017
Priority dateJan 13, 2011
Publication dateMay 8, 2018
Grant dateMay 8, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a compound that comprises the structure: where SIG is a signaling molecule and R 3 is a formyl, a succinyl, a methyl succinyl, or a myristoyl. Also provided is a kit is provided that comprises the above compound, with instructions for determining the presence of the enzyme. Additionally, a method is provided for determining whether a sample has an enzyme that removes a succinyl, a methyl succinyl, a formyl, or a myristoyl moiety from an ε-amino of a lysine. Also provided is a method of determining whether a molecule inhibits an enzyme that removes a succinyl, a methyl succinyl, a formyl, or a myristoyl moiety from an ε-amino of a lysine.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for determining whether at least one molecule inhibits an enzyme that removes a succinyl moiety from an ε-amino of a lysine, the method comprising: (a) combining the enzyme and a molecule with a compound having the formula wherein SIG is a fluorophore or luminescent moiety, and m is an integer from 1 to 10; (b) incubating the enzyme-molecule-compound mixture under conditions and for a time sufficient for the enzyme to remove the succinyl moiety in the absence of the molecule; and (c) determining whether the succinyl moiety is removed from the compound to an equivalent degree that the succinyl moiety would be removed from the compound in the absence of the molecule, wherein the failure of the removal of the succinyl moiety from the compound to an equivalent degree as in the absence of the molecule indicates that the molecule is an inhibitor of the enzyme. 2. The method of claim 1 , wherein the compound is a substrate for a peptidase after the enzyme cleaves the succinyl moiety from the compound but not if the succinyl moiety is not removed from the compound; and wherein the determining step further comprises (i) adding the peptidase to the mixture under conditions and for a time sufficient for the peptidase to cleave the resulting molecule between the nitrogen bound to SIG and the carbonyl carbon bound to said nitrogen, such that SIG generates an increased signal relative to the signal generated with the compound; and (ii) determining whether SIG generates an increased signal relative to the signal generated with the compound, wherein an increased signal indicates the removal of the succinyl moiety from the compound. 3. The method of claim 2 , wherein the peptidase is a trypsin. 4. The method of claim 1 , wherein the enzyme is a histone deacetylase (HDAC). 5. The method of claim 4 , wherein the HDAC is a sirtuin. 6. The method of claim 5 , wherein the sirtuin is SIRT5. 7. The method of claim 1 , wherein SIG is a luminescent moiety. 8. The method of claim 1 , wherein SIG is a fluorophore. 9. The method of claim 1 , wherein the compound is 10. The method of claim 1 , wherein a plurality of different molecules are subjected to the method simultaneously.

Assignees

Inventors

Classifications

  • substituted in position 7 · CPC title

  • Histone deacetylase (3.5.1.98), i.e. sirtuin deacetylase · CPC title

  • C12Q1/34Primary

    involving hydrolase · CPC title

  • Spiro-condensed systems · CPC title

  • acting on amide bonds in linear amides (3.5.1) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9963734B2 cover?
Provided is a compound that comprises the structure: where SIG is a signaling molecule and R 3 is a formyl, a succinyl, a methyl succinyl, or a myristoyl. Also provided is a kit is provided that comprises the above compound, with instructions for determining the presenc…
Who is the assignee on this patent?
Enzo Life Sciences Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).